- Report
- October 2024
- 190 Pages
Global
From €3379EUR$3,545USD£2,845GBP
€3754EUR$3,939USD£3,161GBP
- Report
- October 2024
- 186 Pages
Global
From €3379EUR$3,545USD£2,845GBP
€3754EUR$3,939USD£3,161GBP
- Report
- November 2024
- 150 Pages
Global
From €4622EUR$4,850USD£3,892GBP
- Report
- August 2024
- 145 Pages
Global
From €2858EUR$2,999USD£2,407GBP
- Report
- August 2024
- 144 Pages
Global
From €2383EUR$2,500USD£2,006GBP
- Report
- October 2021
- 139 Pages
Global
From €5670EUR$5,950USD£4,775GBP
- Report
- May 2023
- 140 Pages
Global
From €4717EUR$4,949USD£3,972GBP
- Report
- April 2023
- 112 Pages
Global
From €4527EUR$4,750USD£3,812GBP
- Report
- November 2023
- 190 Pages
Global
From €4289EUR$4,500USD£3,611GBP
- Report
- April 2024
- 108 Pages
Global
From €3500EUR$3,934USD£3,050GBP
- Report
- February 2024
- 86 Pages
Global
From €3500EUR$3,934USD£3,050GBP
The Inhaled Nitric Oxide Delivery System market is composed of inhalers and nebulisers. Inhalers are devices that deliver a precise dose of nitric oxide gas to the lungs, allowing for targeted delivery of the drug. Nebulisers are devices that convert liquid nitric oxide into a mist, which is then inhaled. Both inhalers and nebulisers are used to treat a variety of respiratory conditions, including asthma, chronic obstructive pulmonary disease, and cystic fibrosis.
Inhaled nitric oxide delivery systems are designed to provide a safe and effective way to deliver nitric oxide to the lungs. The devices are designed to be easy to use and to provide accurate dosing. In addition, they are designed to minimize the risk of side effects, such as coughing and throat irritation.
The Inhaled Nitric Oxide Delivery System market is highly competitive, with a number of companies offering products. Some of the major players in the market include Philips Respironics, Vyaire Medical, Fisher & Paykel Healthcare, and ResMed. Show Less Read more
